USPTO serial 87717852
SKY92
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BRACEY, KAREN
- Law office
- TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with SKY92?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas D. Bratschun
Thomas D. Bratschun Adsero IP8210 SOUTHPARK TERRACELITTLETON, CO 80120UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical diagnostic reagents for conducting molecular tests; molecular diagnostic reagents for testing of body substances, namely, bone marrow samples, blood samples, and on human or animal tissue, for medical purposes; molecular diagnostic reagents used to test for cancer for medical purposes; medical diagnostic preparations for use in molecular tests using microarray technology and sequencing technology; genetic identity tests comprised of reagents for medical purposes; preparations for detecting genetic predispositions, namely, for measurement of gene aberrations and mutations, for use with clinical multiplex test assays, and for the determination of the genetic sub-type of a patient; reagents for diagnostic medical testing; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissues in connection with genetic tests, clinical tests, prognostic tests or predictive tests for use in disease detection, namely, hematological disorders; chemical preparations, for medical purposes, for the testing of blood and human or animal tissue for diagnostic purposes | ACTIVE | — |
| 009 | Software featuring algorithms for performing diagnostic tests for medical purposes; software for generating and reading out of the genetic properties of a patient sample; software for interpreting and analyzing raw genetic data for use by laboratory users, molecular biologists, pathologists, physicians and patients, for determining the presence of a genetic aberration, mutation, or gene expression profile, genetic subtype of a disease or clinical consequence thereof and prognosis, whether or not in combination with a specific treatment; computer software for operation of a validated, secure IT infrastructure for clinical purposes; downloadable databases featuring anonymous genetic data of patients from clinical studies for comparison with the genetic outcome of patients samples; software operating and user manuals recorded on CDROMs featuring information on diagnostic testing | ACTIVE | — |
| 042 | Scientific research and development of molecular diagnostic tests; developing software to perform diagnostic tests for medical purposes; development of software, algorithms and databases for translating, analyzing and interpreting test results; molecular diagnostic analysis for scientific research purposes; research and analysis of bodily tissue and fluids and molecular diagnostic test scores for the purpose of developing new biomarkers, testing, and methods of treatment of diseases and disorders; leasing of computer software for reading test results; development, standardization and validation of molecular diagnostic tests; genetic testing for scientific research purposes | ACTIVE | — |
| 044 | Medical analysis services for diagnostic and treatment purposes; analysis of medical and veterinary test scores and data for others for diagnostic and treatment purposes; providing medical and veterinary information; genetic testing for medical purposes; conducting medical tests to determine a patient's prognosis in connection with a disease; providing predictive medical testing for assessing the effectiveness of a medical treatment or to select the medical treatment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 8, 2021 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 8, 2021 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 25, 2021 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Feb 25, 2021 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Feb 25, 2021 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Feb 17, 2021 | ALIE | ASSIGNED TO LIE | — |
| Jul 29, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 29, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 29, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 28, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 23, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 27, 2020 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 27, 2020 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 27, 2020 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 24, 2020 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jul 19, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 19, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 19, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 18, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 18, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 11, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 7, 2019 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Feb 7, 2019 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Feb 7, 2019 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Feb 6, 2019 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 6, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 23, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 23, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 23, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 20, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 19, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 19, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 30, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 22, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 22, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 15, 2017 | NWAP | NEW APPLICATION ENTERED | — |